Catalyst Oncology, a biotech-focused oncology CRO brand under Catalyst Clinical Research, is set to partner with Imerman Angels, a distinguished nonprofit providing personalized one-on-one cancer support free of charge.

The goal of this collaboration is to raise awareness about the support and resources offered by Imerman Angels to cancer patients, survivors, and caregivers, ensuring that nobody faces cancer alone.

Keya Watkins, Senior Vice President of Catalyst Oncology, expressed excitement about the collaboration, stating, "Catalyst is thrilled to team up with Imerman Angels, an organization that shares our dedication to improving the lives of those affected by cancer. This partnership highlights our belief in the strength of community and our commitment to assisting our biotech clients in developing therapies that benefit cancer patients."

Jonny Imerman, Co-founder and Chief Mission Officer of Imerman Angels, also expressed enthusiasm, saying, "We are looking forward to collaborating with Catalyst Oncology. Together, we can expand our reach, provide more support, and have a greater impact on the cancer community."

The collaboration will be officially announced at a private event on National Cancer Survivors Day, a day dedicated to honoring and celebrating cancer survivors, their loved ones, and caregivers. This event coincides with the annual conference of the American Society of Clinical Oncology (ASCO) in Chicago.

 

Source: prnewswire.com

Report Abuse